"The groundwork of all happiness is health." - Leigh Hunt

Vaccines and higher tests against Lyme disease are in preparation

April 25, 2023 – This might be considered one of the last summers that individuals should rely totally on tick checks as their best defense against Lyme disease. Several drugmakers are developing vaccines that would help people avoid the various troubling symptoms of the tick-borne illness.

Earlier this month, Moderna announced it was working on developing two vaccines against Lyme disease. And Pfizer and French vaccine maker Valneva SE plan to submit an application to the FDA in 2025 for his or her joint work on a brand new vaccine against Lyme disease. The vaccine trial is in its final stages. There was a setback when an organization running a part of the trial made mistakes that led to a few of the data being thrown out, although the issues were unrelated to vaccine safety, Pfizer said. announced in February.

Lyme disease is brought on by bacteria that individuals can get from the bite of blacklegged ticks. This particular species typically lives within the northeastern and mid-Atlantic states, the northern states, and the west coast. Symptoms include fever, headache, fatigue, and rash, but they'll worsen and result in problems with the joints, nervous system, and heart, based on the CDC.

Ticks are more lively in the hotter months, and the present ways to stop Lyme disease are applying insect repellent and promptly removing ticks, based on the CDC. There isn't any definitive count of what number of cases of Lyme disease occur annually, as testing may be difficult. But a treasureThe study, based on insurance claims data, found that 476,000 people within the United States are diagnosed and treated for Lyme disease every year.

A two-year, multimillion-dollar competition called LymeX Diagnostics Award is underway wherein scientists are on the lookout for ways to detect lively Lyme disease infections in humans.

Lyme disease vaccines have been available for dogs for years, and a version for humans was approved by the FDA in 1998. But the corporate that made the human vaccine pulled it off the market three years later after Media coverage of side effects led to low demand.

“The main reason is that there was a huge anti-vaccine sentiment towards the vaccine, similar to the measles vaccine. That is illogical,” said Dr. Gregory A. Poland of the Mayo Clinic in a podcast created by the clinic last 12 months.